• Thu, April 4, 2024
Mark Massaro Maintained (ADPT) at Strong Buy with Decreased Target to $5 on, Apr 4th, 2024
Mark Massaro of BTIG, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Strong Buy with Decreased Target from $6 to $5 on, Apr 4th, 2024.
Mark has made no other calls on ADPT in the last 4 months.
There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $5 on, Friday, February 16th, 2024
This is the rating of the analyst that currently disagrees with Mark
- Rachel Vatnsdal of "JP Morgan" Maintained at Buy with Decreased Target to $8 on, Thursday, February 15th, 2024
Like: 👍
